501 related articles for article (PubMed ID: 19351769)
1. Nucleophosmin as a candidate prognostic biomarker of Ewing's sarcoma revealed by proteomics.
Kikuta K; Tochigi N; Shimoda T; Yabe H; Morioka H; Toyama Y; Hosono A; Beppu Y; Kawai A; Hirohashi S; Kondo T
Clin Cancer Res; 2009 Apr; 15(8):2885-94. PubMed ID: 19351769
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of p53 protein in primary Ewing's sarcoma of bone: relationship to tumour stage, response and prognosis.
Abudu A; Mangham DC; Reynolds GM; Pynsent PB; Tillman RM; Carter SR; Grimer RJ
Br J Cancer; 1999 Mar; 79(7-8):1185-9. PubMed ID: 10098757
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of papillomavirus binding factor in Ewing's sarcoma family of tumors conferring poor prognosis.
Yabe H; Tsukahara T; Kawaguchi S; Wada T; Sato N; Morioka H; Yabe H
Oncol Rep; 2008 Jan; 19(1):129-34. PubMed ID: 18097586
[TBL] [Abstract][Full Text] [Related]
4. Pfetin as a prognostic biomarker of gastrointestinal stromal tumors revealed by proteomics.
Suehara Y; Kondo T; Seki K; Shibata T; Fujii K; Gotoh M; Hasegawa T; Shimada Y; Sasako M; Shimoda T; Kurosawa H; Beppu Y; Kawai A; Hirohashi S
Clin Cancer Res; 2008 Mar; 14(6):1707-17. PubMed ID: 18347171
[TBL] [Abstract][Full Text] [Related]
5. [Cooperative Ewing's Sarcoma Studies 81/86: pathologico-anatomic and immunohistochemical findings and differential diagnosis of Ewing sarcoma].
Schmidt D; Harms D
Klin Padiatr; 1988; 200(3):236-42. PubMed ID: 3062261
[TBL] [Abstract][Full Text] [Related]
6. C-kit receptor expression in Ewing's sarcoma: lack of prognostic value but therapeutic targeting opportunities in appropriate conditions.
Scotlandi K; Manara MC; Strammiello R; Landuzzi L; Benini S; Perdichizzi S; Serra M; Astolfi A; Nicoletti G; Lollini PL; Bertoni F; Nanni P; Picci P
J Clin Oncol; 2003 May; 21(10):1952-60. PubMed ID: 12743148
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in non-metastatic Ewing's sarcoma tumor of bone: an analysis of 579 patients treated at a single institution with adjuvant or neoadjuvant chemotherapy between 1972 and 1998.
Bacci G; Longhi A; Ferrari S; Mercuri M; Versari M; Bertoni F
Acta Oncol; 2006; 45(4):469-75. PubMed ID: 16760184
[TBL] [Abstract][Full Text] [Related]
8. A long-term review of the treatment of patients with Ewing's sarcoma in one institution.
Sluga M; Windhager R; Lang S; Heinzl H; Krepler P; Mittermayer F; Dominkus M; Zoubek A; Kotz R
Eur J Surg Oncol; 2001 Sep; 27(6):569-73. PubMed ID: 11520091
[TBL] [Abstract][Full Text] [Related]
9. Interactomic approach for evaluating nucleophosmin-binding proteins as biomarkers for Ewing's sarcoma.
Haga A; Ogawara Y; Kubota D; Kitabayashi I; Murakami Y; Kondo T
Electrophoresis; 2013 Jun; 34(11):1670-8. PubMed ID: 23483572
[TBL] [Abstract][Full Text] [Related]
10. Absence of HER2/neu gene expression in osteosarcoma and skeletal Ewing's sarcoma.
Thomas DG; Giordano TJ; Sanders D; Biermann JS; Baker L
Clin Cancer Res; 2002 Mar; 8(3):788-93. PubMed ID: 11895910
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of tumor protein D52 immunostaining in a large series of Ewing's sarcoma family of tumors.
Machado I; López-Guerrero JA; Calabuig-Fariñas S; Hardy JR; Scotlandi K; Picci P; Byrne JA; Llombart-Bosch A
Pediatr Dev Pathol; 2011; 14(3):255-6. PubMed ID: 21338318
[No Abstract] [Full Text] [Related]
12. Induction of cell death by basic fibroblast growth factor in Ewing's sarcoma.
Sturla LM; Westwood G; Selby PJ; Lewis IJ; Burchill SA
Cancer Res; 2000 Nov; 60(21):6160-70. PubMed ID: 11085540
[TBL] [Abstract][Full Text] [Related]
13. Expression of functional CD40 on human osteosarcoma and Ewing's sarcoma cells.
Lollini PL; Landuzzi L; Frabetti F; Rossi I; Nicoletti G; Scotlandi K; Serra M; Baldini N; De Giovanni C; Nanni P
Clin Cancer Res; 1998 Aug; 4(8):1843-9. PubMed ID: 9717810
[TBL] [Abstract][Full Text] [Related]
14. Ewing's sarcoma of jaw bones in adult patients: 10-year experiences in a Paris university hospital.
Pitak-Arnnop P; Bellefqih S; Bertolus C; Chaine A; Dhanuthai K; Gruffaz F; Bertrand JC
J Craniomaxillofac Surg; 2008 Dec; 36(8):450-5. PubMed ID: 18674924
[TBL] [Abstract][Full Text] [Related]
15. Immunophenotypic profile of biomarkers related to anti-apoptotic and neural development pathways in the Ewing's family of tumors (EFT) and their therapeutic implications.
Navarro S; Giraudo P; Karseladze AI; Smirnov A; Petrovichev N; Savelov N; Alvarado-Cabrero I; Llombart-Bosch A
Anticancer Res; 2007; 27(4B):2457-63. PubMed ID: 17695539
[TBL] [Abstract][Full Text] [Related]
16. Ewing's sarcoma and the development of secondary malignancies.
Fuchs B; Valenzuela RG; Petersen IA; Arndt CA; Sim FH
Clin Orthop Relat Res; 2003 Oct; (415):82-9. PubMed ID: 14612633
[TBL] [Abstract][Full Text] [Related]
17. Ewing's sarcoma: value of tumor necrosis as a predictive factor.
de Stéfani E; Carzoglio J; Deneo Pellegrini H; Olivera L; Cendan M; Kasdorf H
Bull Cancer; 1984; 71(1):16-21. PubMed ID: 6713111
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of Vascular Endothelial Growth Factor-A expression in Ewing's sarcoma.
Kreuter M; Paulussen M; Boeckeler J; Gerss J; Buerger H; Liebscher C; Kessler T; Jurgens H; Berdel WE; Mesters RM
Eur J Cancer; 2006 Aug; 42(12):1904-11. PubMed ID: 16824746
[TBL] [Abstract][Full Text] [Related]
19. Xg expression in Ewing's sarcoma is of prognostic value and contributes to tumor invasiveness.
Meynet O; Scotlandi K; Pradelli E; Manara MC; Colombo MP; Schmid-Antomarchi H; Picci P; Bernard A; Bernard G
Cancer Res; 2010 May; 70(9):3730-8. PubMed ID: 20388798
[TBL] [Abstract][Full Text] [Related]
20. [Clinicopathological study of Ewing's sarcoma/primitive neuroectodermal tumor in oral and maxillofacial region].
He HW; Liu LK; Li YN; Wang D; He ZX
Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Sep; 40(5):379-82. PubMed ID: 16255919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
